Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Super-Zoom Confocal Microscope Allows 3D Navigation Through Sample

By Labmedica staff writers
Posted on 08 Apr 2008
New technologies have been developed in confocal and stereomicroscopy for ultra-high resolutions, from macro to nano, in laboratory and life science sectors. More...
One of these is the super-zoom three-dimensional (3D) confocal system--its automated zoom allows seamless magnification change from overview to detail with free 3D navigation through the sample--from embryo to cell, from cell to genome.

Presented by Leica Microsystems (Wetzlar, Germany) at Analytica 2008 (Munich, Germany), which took place on April 1-4, 2008, the Leica TCS LSI has made it possible to identify influences of genetic defects on the living model organism or to study in vivo the development from a cell to the entire organism in every detail. Combining high confocal resolution with a large field-of-view of up to 16 mm, the Leica TCS LSI enables unique in vivo imaging of large samples.

The Leica Microsystems launched its new Leica TCS SP5 X supercontinuum confocal system, providing freedom and flexibility that were previously unattainable with fluorescence microscopy, visibly improving results. The innovative supercontinuum laser allows the investigator to choose any excitation line within the continuous range of 470 to 670 nm. The Leica TCS SP5 X precisely adapts to any fluorescent dye. Optimal adjustment of the excitation line to the sample--in 1-nm increments--reduces cross-excitation and minimizes sample damage. The Leica TCS SP5 X also allows multi-color excitation with up to eight excitation lines simultaneously.

The Leica M205 C uses FusionOptics to offer a new dimension in stereomicroscopy. Leica FusionOptics makes advantageous use of a neurologic phenomenon: the left beam path produces great depth of field, while the right beam path provides a high-resolution image. The human brain itself then combines the best information from both channels, using it to compose an image whose resolution and depth of field have never been achieved in any stereomicroscope before.

The endoscopic confocal microscope Leica FCM1000 enables non-invasive real-time examinations to be conducted on living animals. High-speed recordings can be made of cellular or vascular processes simply by bringing the flexible and minimally invasive micro probe in contact with the tissue of interest. This new method allows repeat measurements as well as follow-up analysis of living processes on the same animal. The innovative fiber-optic confocal fluorescence microscope Leica FCM1000 was developed by Leica Microsystems' partnering company Mauna Kea Technologies (Paris, France) and is fully adapted to in-vivo and in situ small animal imaging.

New prospects are offered for research in proteomics and genomics, toxicology, and neurobiology by the Leica LMD6000 laser microdissection system. Featuring automated cell recognition and an integrated scanning table with a holding fixture for up to three specimens, the new laser microdissection system provides excellent sample throughput.

The Leica CM1950 cryostat platform for pathologists comprises a standard instrument plus a range of options that allow each laboratory to configure a cryostat that matches their individual needs. To ensure the Leica CM1950 meets the needs of cryostat users, Leica Microsystems have introduced two significant features: the CryoZone cooling system and the optional vacuum waste removal system. The CryoZone system controls a zone of uniformly cool air in the critical areas of the cryochamber. The optional vacuum system aids workflow and safety, saving time by keeping sections flat, wrinkle-free, and enhancing operator safety by removing waste material.


Related Links:
Leica Microsystems
Analytica 2008
Mauna Kea Technologies

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.